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Abstract
Increased attention has been focused in marine invertebrates as a source of bioactive molecules for biomedical 
applications. Many bioactive molecules are part of the innate immune system. Some more recently isolated compounds, 
mainly from sea urchin and sea cucumber are antimicrobial peptides (AMP) active against Gram positive, Gram 
negative and fungi. In this review we described the most recent studies on AMP isolated from echinoderms. The 
AMP are little peptides <10 kDa with cationic charge and amphipathic structure. Recently, it was demonstrated that 
in the coelomocyte lysates of Paracentrotus. lividus and Holothuria tubulosa AMP are present with activity against 
staphylococcal and Pseudomonas aeruginosa antibiofilm. The data show the great potential of application of AMPs 
in biotechnology for developing novel therapeutic agents and as complements to conventional antibiotic therapy to 
combat the multi - resistant bacterial strains.
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Introduction
Echinoderms are an ancient group of marine invertebrates that live 
in both the intertidal and deep sea benthos composed approximately 
by 7000 extant species that including sea stars (asteroids), sea urchin 
(echinoids), sea cucumbers (holothurians), brittle stars (ophiuroids) 
and sea lilies (crinoids). Because, many species live in near the coastal 
or estuaries waters overloaded with infectious organisms, such as 
virus, bacteria, fungi and other parasites, they are exposed to a broad 
variety of challenges to their self-integrity. To survive in high impact 
environments have evolved efficient defense strategies.
Echinoderms, similarly to other invertebrates, do not possess 
a specific immune response. Therefore they ensure the protection of 
their organism and its homeostasis using natural immunity responses. 
Among the innate immune system humoral components, antimicrobial 
peptides (AMPs) are the major defense molecules of innate immunity 
and are widespread in nature. Indeed they are produced by living 
organisms of all kingdoms throughout the bacteria and animal including 
fungi and plants [1-8]. Currently, more than 4000 peptides have been 
isolated and characterized from tissues and organisms and have been 
listed in the main databases (Table 1), or in journal publications [9].
Usually, AMPs have small molecular weight with no more 100 
amino acids and a molecular weight <10 kDa. They differ considerably 
in amino acid sequence and structural conformation and most of 
them are positively charged showing a net positive charge of +2 to +9 
due to an excess number of acidic, with a hydrophobic face opposite 
to hydrophilic one. These chemo-physical characteristics allow these 
peptides to be soluble in water but react simultaneously with the 
hydrophobic layer of microbial membranes.
The mode of action of AMPs has rarely been addressed and is 
therefore not yet understood [10]. It is generally agreed that the AMPs 
are initially recruited on the microbial surface through electrostatic 
interaction between cationic portion of the peptides and the negatively-
charged microbial cell walls and/or membranes. When, the peptide/
lipid ratio increases, the peptides start forming multimers or self-
associating on top of the membrane. When the peptides reach a high 
concentration they orientate perpendicularly and insert into the bilayer, 
thereby interfering with membrane integrity. The microorganisms are 
then destroyed or via membrane destabilization and/or pore formation 
[10,11] or through interference with several essential metabolic 
functions, such as protein, nucleic acid and cell wall syntheses acting on 
nucleic acids and/or enzymatic proteins, leading to bacterial cell death 
[10-14]. Moreover, it appears that many AMPs may be multifunctional 
microbicides, acting simultaneously at the cell membrane and internal 
sites [11].
In invertebrates, AMPs are ubiquitous distributed, found especially 
in hemolymph and in tissues such as epidermis, gut and respiratory 
organs where exposure to pathogenic microorganisms is most likely, 
expressed constitutively or in response to a pathogen stimulus. The 
AMPs defend the organisms not only through their ability to kill bacteria, 
but it was shown that they have antitumor effects, mitogenic activity 
and, most importantly, participate in immunoregulatory mechanisms 
by modulating signal transduction and cytokine production and/or 
release [3,11,12,15-22].
The purpose of this mini-review will be to present the most recent 
data on antimicrobial peptides isolated and characterized in the 
phylum Echinoderms. In particular we will focus on their structure, 
biological functions and in their potential application as antimicrobial 
and antibiofilm agents to contrast human pathogens. 
Antimicrobial Peptides in Echinoderms
Truong et al. [23] discovered, for the first time in echinoderm, the 
presence of AMPs in the coleomic fluid of the sea cucumber Cucumaria 
frondosa. Since 2001 the number of molecules has increased steadily. 
They can be mainly found in coelomocytes, the effector cells of 
immunity, and occasionally in coelomic fluid. In some cases have been 
also found in the gastrointestinal organs, in the eggs and in the body 
wall [24]. Many of AMPs are derived from larger proteins that could 
be enzymatically digested and produce active fragments. This has been 
demonstrated by Ghanbari et al. [25]. In fact, by digesting the tissues 
of sea cucumber Actinopyga lecanora with bromelain, peptides with 
inhibitory activities against respectively Pseudomonas sp., P. aeruginosa 
and E. coli were obtained and one papain digested fraction showed 
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antibacterial activity against S. aureus. Aleshina et al. [26], found that 
among the AMPs isolated in starfish Asterias rubens, two peptides were 
part of histone molecule H2A. Maltseva and co-workers also found that 
two other peptides were fragments of actin, while one peptide was a 
fragment of filamin A. 
A fraction at low molecular weight (<5kDa) acid extract of 
Paracentrotus livudus coelomocytes contained an antimicrobial peptide 
active against Gram positive and Gram negative pathogens [27]. The 
peptide belonging to the segment (9-19) of a β-thymosin, a ubiquitous 
peptide that possesses several biological effects as such as induction 
of metalloproteinases, chemotaxis, angiogenesis and inhibition of 
inflammation [28]. The β thymosins are a family of highly conserved 
polar 5-kDa peptides originally thought to be thymic hormones. They 
are present at high concentrations in almost every cell from vertebrate 
phyla and have several biological functions due to direct and indirect 
effects on the actin cytoskeleton. β-Thymosin is also described as one 
of the AMP of platelets from animals and human beings [29]. There is 
little information about the function of thymosins in invertebrates, but 
their presence has been reported in marine invertebrates [30,31] and in 
insects where they are up regulated by microbial infections [32].
Cystein Rich Antimicrobial Peptides
Antimicrobial peptides in echinoderms are generally heterogeneous 
molecules and until a few years ago it was not possible to sort them 
into classes of molecules. Li [33] discovered in Strongylocentrotus 
droebachiensis two AMPs called Strongylocins (Table 2). The 
strongylocin peptides are members of the cysteine-rich AMP family, 
which have six cysteines with three disulfide bonds involved in peptide 
conformation, stabilization and resistance to proteases [34] and which 
are crucial for the antimicrobial activity [35,36]. The strongylocins 
show different pattern with the other members of the family suggesting 
that the change in molecular conformation could allow resisting to 
the proteolysis within the coelomocytes and in the coelomic fluid. 
Homologues are also present in the sister species S. purpuratus, called 
SpStrongylocins [37]. Furthermore, in S. purpuratus Li et al. [38] have 
found other two AMPs called centriocins with a potent activity against 
Gram-positive and Gram-negative bacteria. These are heterodimeric 
molecules consisting of two subunits, a heavy chain of (30 amino 
acids) and a light chain (12 amino acids) linked by an intramolecular 
disulfide bridge. Novel synthetic peptides sequentially derived from the 
AMP centrocin 1, were recently tested for their anti-infective and anti-
inflammatory effects [39].
Antimicrobial Biofilm Peptides
The biofilm is a complex community of microbial cells that are 
associated with a surface and enclosed in a self-produced biopolymer 
matrix (Figure 1). The capability to organise a biofilm community is 
present in almost all Gram-negative and Gram positive bacteria and 
several of them can be highly pathogenic for animals and human 
beings. The pathogenic role of bacterial biofilms is well known in 
human health, because they are responsible for chronic infections and 
device and biomaterial associated infections [40-42].
Antibiotics can be efficacious against planktonic (free living) 
pathogens but are quite often poorly effective against the bacteria 
organized in community which can increase antibiotic resistance by up 
to 1000 fold [43]. Biofilm structured bacteria develop a multifactorial 
mechanism of resistance to antibiotics, but the most important factor 
of tolerance is due to the slow growth and low metabolic activity 
of bacterial cells in the internal layer of community, so they are 
intrinsically resistant to conventional antibiotics which target dividing 
and metabolically active cells. 
On the contrary, the prevalent mechanism of action of AMPs 
is due to their ability to permeabilize and/or to form pores within 
the cytoplasmic membranes, so they have a high potential to act 
also on slow-growing or even non growing bacteria that exhibit a 
reduced susceptibility to many antibiotics and represent a reservoir 
for recurrent biofilm infections. The AMPs also have a high potential 
for inhibiting biofilm formation, in fact, they can act at several stages 
of biofilm formation and with different mechanisms of action: they 
may minimize initial adhesion of microbial cells to abiotic surfaces 
by altering the adhesive features of abiotic surfaces, or by binding to 
Name n. of listed antimicrobial 
peptides
Origin Web address
CAMP 4020 Prokaryotes and eukaryotes http://www.bicnirrh.res.in/antimicrobial/  
DAMPD 1232 Prokaryotes and eukaryotes http://apps.sanbi.ac.za/dampd/ 
APD 2221 Prokaryotes and eukaryotes http://aps.unmc.edu/AP/main.php 
AMSDB 895 Eukaryotic http://www.bbcm.units.it/~tossi/amsdb.html  
BACTIBASE 177 Bacteriocin http://bactibase.pfba-lab-tun.org/statistics.php   
DEFENSINS KNOWLEDGEBASE 363 Defensin http://defensins.bii.a-star.edu.sg/  
PhytAMP 271 Plant http://phytamp.pfba-lab-tun.org/main.php  
Table 1: List of Peptides which are isolated and characterized from tissues and organisms.
a. Initial attachment and 
anchorage to surface
b. Production of EPS c. Accumulation of EPS 
and grow
d. Detachment of 
biofilm cells and 
dispersion
Figure 1: The cycle of biofilm. a: attachment of planktonic cells to a surface. b: Recruitment of other planktonic cells and production of EPS. c: growth and development 
of biofilm through cell division and recruitment. d: dispersion of bacteria from biofilm.
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microbial surfaces via electrostatic interactions, or may prevent biofilm 
maturation by killing the early surface colonizers, or by inhibiting 
quorum sensing (QS), that is the communication system used by many 
bacteria to build a biofilm. QS is a system composed by small molecules 
that control collective behaviors, such as bioluminescence, virulence 
factor production, and biofilm formation [44-47].
As shown in Figure 1, biofilm-formation is generally initiated by 
the attachment of planktonic cells to a surface through weak van der 
Waals forces and the colonists are anchored tightly or irreversibly by pili 
(Figure 1a). To recruit other planktonic cells, the initial cells construct 
various adhesion sites and the matrix, an extracellular polymeric 
substance (EPS) (Figure 1b). EPS is composed of extracellular DNA, 
proteins, lipids, and polysaccharides with various configurations [48]. 
These components are very important targets for overcoming both 
biofilms and drug-resistant bacteria [49]. During colonization, some 
bacteria can communicate through a quorum sensing (QS) system. 
Subsequently, the grown or developed biofilm provides increased 
antibiotic-resistance to bacterial colonies through cell division and 
recruitment (Figure 1c). Later, the developed biofilms are dispersed 
and the bacteria move to other surfaces, (Figure 1d), where the biofilm 
formation process occurs again.
The mode of action of antibiotic peptides against biofilm is not fully 
understood, but it is believed that their major targets are cytoplasmic 
membrane and intracellular molecules [14,50]. It is also believed that 
it is very difficult for bacteria to develop resistance to antimicrobial 
peptides because most kill bacterial cells quickly through their actions 
on the entire cytoplasmic membrane or can act through complex 
mechanism [51].
Recently our research group has found novel peptides in P. lividus 
and in H. tubulosa, with a good activity in preventing biofilm formation 
of important pathogens involved in human and animal diseases, like 
staphylococcal or P. aeruginosa strains [27,52]. Sub-MIC concentrations 
of the 5-kDa peptide fraction of the cytosol from coelomocytes of 
P.lividus were active to inhibit the formation of young (6 hours old) and 
mature (24 hours old) staphylococcal biofilm [27]. 
The synthetic peptides derived from AMP of H. tubulosa were able 
to inhibit biofilm formation against staphylococcal and Pseudomonas 
aeruginosa strains [53-55].
The anti-adhesion property of the tested peptides could be also 
very important against food transmitted pathogens and to contrast the 
biofilm mode of growth of various organisms involved in food spoilage. 
In conclusion, the discovery of novel peptides in Echinoderms 
represents a good starting point to design new synthetic derivatives 
with modified chemical-physical properties, with the aim to improve 
their antimicrobial activity against pathogens and their pharmaceutical 
potential [46,47].
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